Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations.

Cariello M, Piccinin E, Garcia-Irigoyen O, Sabbà C, Moschetta A.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1308-1318. doi: 10.1016/j.bbadis.2017.09.019. Epub 2017 Sep 29. Review.

2.

Bile acids and colon cancer: Is FXR the solution of the conundrum?

Gadaleta RM, Garcia-Irigoyen O, Moschetta A.

Mol Aspects Med. 2017 Aug;56:66-74. doi: 10.1016/j.mam.2017.04.002. Epub 2017 Apr 21. Review.

PMID:
28400119
3.

A Novel Protective Role for FXR against Inflammasome Activation and Endotoxemia.

Garcia-Irigoyen O, Moschetta A.

Cell Metab. 2017 Apr 4;25(4):763-764. doi: 10.1016/j.cmet.2017.03.014.

4.

Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD).

Gadaleta RM, Garcia-Irigoyen O, Moschetta A.

Curr Protoc Mouse Biol. 2017 Mar 2;7(1):13-28. doi: 10.1002/cpmo.20.

PMID:
28252200
5.

The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells.

Vilaseca M, García-Calderó H, Lafoz E, García-Irigoyen O, Avila MA, Reverter JC, Bosch J, Hernández-Gea V, Gracia-Sancho J, García-Pagán JC.

Hepatology. 2017 Jun;65(6):2031-2044. doi: 10.1002/hep.29084. Epub 2017 May 2.

PMID:
28142199
6.

Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats.

Cerini F, Vilaseca M, Lafoz E, García-Irigoyen O, García-Calderó H, Tripathi DM, Avila M, Reverter JC, Bosch J, Gracia-Sancho J, García-Pagán JC.

J Hepatol. 2016 Apr;64(4):834-42. doi: 10.1016/j.jhep.2015.12.003. Epub 2015 Dec 11.

PMID:
26686269
7.

Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1/C-X-C chemokine receptor 4 axis.

García-Irigoyen O, Latasa MU, Carotti S, Uriarte I, Elizalde M, Urtasun R, Vespasiani-Gentilucci U, Morini S, Benito P, Ladero JM, Rodriguez JA, Prieto J, Orbe J, Páramo JA, Fernández-Barrena MG, Berasain C, Avila MA.

Hepatology. 2015 Jul;62(1):166-78. doi: 10.1002/hep.27798. Epub 2015 Apr 22.

PMID:
25808184
8.

Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.

Uriarte I, Latasa MU, Carotti S, Fernandez-Barrena MG, Garcia-Irigoyen O, Elizalde M, Urtasun R, Vespasiani-Gentilucci U, Morini S, de Mingo A, Mari M, Corrales FJ, Prieto J, Berasain C, Avila MA.

Int J Cancer. 2015 May 15;136(10):2469-75. doi: 10.1002/ijc.29287. Epub 2014 Nov 6.

9.

Splicing regulator SLU7 is essential for maintaining liver homeostasis.

Elizalde M, Urtasun R, Azkona M, Latasa MU, Goñi S, García-Irigoyen O, Uriarte I, Segura V, Collantes M, Di Scala M, Lujambio A, Prieto J, Ávila MA, Berasain C.

J Clin Invest. 2014 Jul;124(7):2909-20. doi: 10.1172/JCI74382. Epub 2014 May 27.

10.

Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis.

Berasain C, Elizalde M, Urtasun R, Castillo J, García-Irigoyen O, Uriarte I, Latasa MU, Prieto J, Avila MA.

Hepat Oncol. 2014 Apr;1(2):241-252. doi: 10.2217/hep.13.17. Epub 2014 Mar 20. Review.

11.

Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair.

Garcia-Irigoyen O, Carotti S, Latasa MU, Uriarte I, Fernández-Barrena MG, Elizalde M, Urtasun R, Vespasiani-Gentilucci U, Morini S, Banales JM, Parks WC, Rodriguez JA, Orbe J, Prieto J, Páramo JA, Berasain C, Ávila MA.

Liver Int. 2014 Aug;34(7):e257-70. doi: 10.1111/liv.12337. Epub 2013 Oct 16.

PMID:
24119197
12.

Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system.

Latasa MU, Salis F, Urtasun R, Garcia-Irigoyen O, Elizalde M, Uriarte I, Santamaria M, Feo F, Pascale RM, Prieto J, Berasain C, Avila MA.

PLoS One. 2012;7(12):e52711. doi: 10.1371/journal.pone.0052711. Epub 2012 Dec 20.

13.

Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism.

Berasain C, Nicou A, Garcia-Irigoyen O, Latasa MU, Urtasun R, Elizalde M, Salis F, Perugorría MJ, Prieto J, Recio JA, Corrales FJ, Avila MA.

Dig Dis. 2012;30(5):524-31. doi: 10.1159/000341705. Epub 2012 Oct 24.

PMID:
23108309
14.

Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation.

Urtasun R, Latasa MU, Demartis MI, Balzani S, Goñi S, Garcia-Irigoyen O, Elizalde M, Azcona M, Pascale RM, Feo F, Bioulac-Sage P, Balabaud C, Muntané J, Prieto J, Berasain C, Avila MA.

Hepatology. 2011 Dec;54(6):2149-58. doi: 10.1002/hep.24587.

PMID:
21800344
15.

Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer.

Berasain C, Ujue Latasa M, Urtasun R, Goñi S, Elizalde M, Garcia-Irigoyen O, Azcona M, Prieto J, Avila MA.

Cancers (Basel). 2011 May 18;3(2):2444-61. doi: 10.3390/cancers3022444.

Supplemental Content

Loading ...
Support Center